Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity
- PMID: 18984791
- DOI: 10.1354/vp.45-6-889
Survival of dogs following surgical excision of histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity
Abstract
Postsurgical follow-up information was obtained on 64 dogs with 69 histologically well-differentiated melanocytic neoplasms that involved the mucous membranes of the lips and oral cavity. The patients received no adjunct therapy. Sixty one of 64 dogs (95%) were alive at the end of the study or had died of causes unrelated to the tumor, with a mean survival of 23.4 months and a median survival of 34 months after surgery. Twenty-eight dogs alive at the end of the study had a mean survival of 31.3 months after surgery. There were 2 dogs, which had recurrent tumors, that were still alive at the end of the study. All dogs that died of tumor-related causes (3) and all dogs with recurrent tumors (2) had tumors in the oral cavity. Results of this study indicate that a favorable clinical course and prolonged survival can be expected in most dogs with histologically well-differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity, with only local excision of the lesions and no adjunct therapy.
Similar articles
-
Prognostic criteria for dogs with oral melanoma.J Am Vet Med Assoc. 1981 Mar 15;178(6):580-2. J Am Vet Med Assoc. 1981. PMID: 7263464 No abstract available.
-
Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.Vet Pathol. 2011 Nov;48(6):1204-11. doi: 10.1177/0300985810396517. Epub 2011 Feb 3. Vet Pathol. 2011. PMID: 21292918
-
Prognosis after surgical excision of canine melanomas.Vet Pathol. 1979 Jan;16(1):32-40. doi: 10.1177/030098587901600103. Vet Pathol. 1979. PMID: 462717
-
Principles of oncologic orofacial surgery.Clin Tech Small Anim Pract. 1998 Feb;13(1):38-41. doi: 10.1016/S1096-2867(98)80025-X. Clin Tech Small Anim Pract. 1998. PMID: 9634345 Review.
-
Mandibulectomy and maxillectomy.Vet Clin North Am Small Anim Pract. 2005 Jul;35(4):1009-39, viii. doi: 10.1016/j.cvsm.2005.03.005. Vet Clin North Am Small Anim Pract. 2005. PMID: 15979523 Review.
Cited by
-
Canine Oral Melanoma: Questioning the Existing Information through a Series of Clinical Cases.Vet Sci. 2024 May 17;11(5):226. doi: 10.3390/vetsci11050226. Vet Sci. 2024. PMID: 38787198 Free PMC article.
-
Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.Pigment Cell Melanoma Res. 2016 Nov;29(6):643-655. doi: 10.1111/pcmr.12512. Epub 2016 Sep 22. Pigment Cell Melanoma Res. 2016. PMID: 27463366 Free PMC article.
-
Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison.Genes (Basel). 2019 Jun 30;10(7):501. doi: 10.3390/genes10070501. Genes (Basel). 2019. PMID: 31262050 Free PMC article. Review.
-
Breed-predispositions to cancer in pedigree dogs.ISRN Vet Sci. 2013 Jan 17;2013:941275. doi: 10.1155/2013/941275. Print 2013. ISRN Vet Sci. 2013. PMID: 23738139 Free PMC article.
-
Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma.Cancer Immunol Immunother. 2018 Oct;67(10):1533-1544. doi: 10.1007/s00262-018-2201-5. Epub 2018 Jul 26. Cancer Immunol Immunother. 2018. PMID: 30051333 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical